HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Vincent R Bonagura Selected Research

Recurrent respiratory papillomatosis

12/2015Poly(I:C) induces controlled release of IL-36γ from keratinocytes in the absence of cell death.
4/2012Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
1/2012T(H)2-like chemokine patterns correlate with disease severity in patients with recurrent respiratory papillomatosis.
6/2010Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.
2/2010Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.
9/2008Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis.
3/2004Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Vincent R Bonagura Research Topics

Disease

7Infection
12/2013 - 05/2004
5Papilloma (Papillomatosis)
12/2015 - 02/2005
3Neoplasms (Cancer)
01/2012 - 09/2008
3Rare Diseases (Rare Disease)
06/2010 - 03/2004
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
08/2014 - 12/2006
2Lymphopenia (Lymphocytopenia)
08/2014 - 12/2006
2Pneumonia (Pneumonitis)
01/2014 - 12/2013
1Deficiency Diseases (Deficiency Disease)
01/2013
1Hypersensitivity (Allergy)
06/2012
1Lung Diseases (Lung Disease)
12/2006
1Tetanus
05/2005
1Chickenpox
05/2005
1Rubella (German Measles)
05/2005
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2005
1Mumps
05/2005
1Measles
05/2005
1Hepatitis B
05/2005
1Virus Diseases (Viral Diseases)
05/2005
1Laryngeal Diseases
02/2005
1Tracheal Diseases
02/2005

Drug/Important Bio-Agent (IBA)

7Recurrent respiratory papillomatosisIBA
12/2015 - 03/2004
3Immunoglobulins (Immunoglobulin)IBA
08/2014 - 01/2013
3Immunoglobulin G (IgG)IBA
12/2013 - 07/2008
3Messenger RNA (mRNA)IBA
04/2012 - 05/2004
1VaccinesIBA
08/2014
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2014
1Anti-Bacterial Agents (Antibiotics)IBA
08/2014
1Bruton type agammaglobulinemiaIBA
01/2014
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2013
1harpin (messenger)IBA
01/2012
1KIR ReceptorsIBA
02/2010
1RNA (Ribonucleic Acid)IBA
09/2008
1Interleukin-7 Receptors (Interleukin 7 Receptor)IBA
12/2006
1Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link
05/2005
1temoporfinIBA
02/2005
11-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2005
1Interleukin-18 (Interleukin 18)IBA
05/2004
1Interleukin-2 (IL2)IBA
05/2004

Therapy/Procedure

1Immunotherapy
06/2012
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2006
1Transplantation (Transplant Recipients)
12/2006
1Drug Therapy (Chemotherapy)
05/2005